Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 November 1995 | Volume 123 Issue 9 | Pages 673-675
Objective: To describe the effects of menopause on resting metabolic rate, body composition, fat distribution, physical activity during leisure time, and fasting insulin levels.
Design: A longitudinal comparison of metabolic changes in women who experienced menopause with changes in age-matched women who did not experience menopause.
Setting: General clinical research center.
Patients: An initial cohort of 35 sedentary healthy premenopausal women (age range, 44 to 48 years). After 6 years of follow-up, 18 women had spontaneously stopped menstruating for at least 12 months and 17 women remained premenopausal. No women received hormone replacement therapy.
Results: Women who experienced menopause lost more fat-free mass than women who remained premenopausal (3.0 ± 1.1 kg and 0.5 ± 0.5 kg, respectively), had greater decreases in resting metabolic rate (103 ± 55 kcal/d and 8 ± 17 kcal/d) and physical activity during leisure time (127 ± 79 kcal/d and 64 ± 60 kcal/d), and had greater increases in fat mass (2.5 ± 2 kg and 1.0 ± 1.5 kg), fasting insulin levels (11 ± 9 pmol/L and 2 ± 5 pmol/L), and waist-to-hip ratios (0.04 ± 0.01 and 0.01 ± 0.01) (P
Conclusions: Natural menopause is associated with reduced energy expenditure during rest and physical activity, an accelerated loss of fat-free mass, and increased central adiposity and fasting insulin levels. These changes may indicate a worsening cardiovascular and metabolic risk profile.
Several cross-sectional studies have suggested that decreases in resting metabolic rate and physical activity may be accelerated in the postmenopausal years [4-6]. The decrease in energy expenditure during rest and physical activity may be related to the decreased fat-free mass that has been seen in postmenopausal women [7-9]. More-over, the decrease in energy expenditure may result in increased fat mass if daily energy intake is not reduced accordingly. Other researchers, however, have not found that menopause independently affects body weight gain [10, 11].
These studies [4-11] have provided incomplete information on menopause-related changes in energy expenditure and body composition. Cross-sectional designs do not allow a robust examination of the effects of menopause on metabolic and cardiovascular risk factors, and no longitudinal studies have included measures of resting metabolic rate and body composition. To this end, we compared longitudinal changes in resting metabolic rate, body composition, and physical activity in a cohort of healthy premenopausal women who experienced menopause with changes in these variables in a cohort of women who remained premenopausal.
Thirty-eight healthy, nonsmoking, premenopausal white women (age range, 44 to 48 years) were tested for baseline metabolic characteristics. Women were recruited from the surrounding communities through advertisements in the local newspaper and radio and were then screened by a telephone interview. None had coronary heart disease (for example, ST-segment depression greater than 1 mm at rest or during a modified Balke exercise test), cardiomyopathy, or hypertension (resting blood pressure greater than 140/90 mm Hg); were receiving medications that could affect cardiovascular function or metabolic rate; or had a medical history of diabetes. All premenopausal women were tested between days 5 and 12 of the follicular phase of their menstrual cycle. Menopause status was determined by interview.
Six years later, patients participated in an identical series of metabolic tests, for which identical testing equipment was used. The reproducibility of the metabolic tests over this time period has previously been reported [5]. After follow-up, 18 women had spontaneously stopped menstruating for at least 12 months (2 ± 1 years after menopause began), and 17 reported normal menstrual function. We excluded three perimenopausal women from the analyses. None of the women had received hormone replacement therapy. The Committee on Human Research for the Medical Sciences approved the study, and each volunteer provided written informed consent before the study began.
Timing and Description of Metabolic Tests
The study methods have been previously described [4]. Briefly, resting metabolic rate was measured for 45 minutes on the morning (0730 hours) after a 12-hour overnight fast. Each volunteer was placed in a supine position, and a clear plastic hood was placed over her head. Room air was continuously drawn through the hood, and the flow rate was measured by a pneumotachograph. Oxygen consumption (VO2) and CO2 production were continuously measured and analyzed during this period and were converted to a caloric equivalent (kcal/d) [12]. Peak VO2 was assessed by a progressive, symptom-limited treadmill exercise test. Body fat was estimated from body density by underwater weighing [13], and fat-free mass was calculated as total body mass minus fat mass. Waists were measured at the minimal circumference between the xiphoid process and the superior anterior iliac crest, and hips were measured at the maximal protrusion of the buttocks. The physical activity level during leisure time was measured using a structured interview [14]. Plasma glucose levels were determined using a YSI glucose analyzer (Yellow Springs Instruments, Yellow Springs, Ohio). Plasma immunoreactive insulin levels were determined by radioimmunoassay. Food intake was measured from 3-day food intake diaries (2 weekdays and 1 weekend day). We used a Student t-test to compare changes in the outcome measures between baseline and the end of follow-up within each subgroup. Values are expressed as the mean ±SD. BRIEF COMMUNICATION
Editor's Note: Publication of this article has been rescinded. Please see the Notice of Retraction.
Changes in Energy Balance and Body Composition at Menopause: A Controlled Longitudinal Study
0.01 for all comparisons). Menopause did not affect energy intake, fasting glucose levels, or peak oxygen consumption.
Menopause heralds the onset of physiologic changes that increase the risk for cardiovascular disease [1-3]. Although many women report increased body weight during menopause, no longitudinal studies have examined energy intake and energy expenditure and their association with changes in body composition and fat distribution.
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Patients
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Baseline physical characteristics of the cohort of premenopausal women are shown in Table 1. No differences were seen between the baseline characteristics of women who experienced natural menopause and those of women who remained premenopausal (Table 1). When women were retested after 6 years of follow-up, 18 were classified as postmenopausal and 17 remained premenopausal. Although total body weight did not differ between groups after follow-up, the composition of body weight showed distinct differences. Postmenopausal women lost more fat-free mass and gained more fat mass than women who remained premenopausal (Table 1). Women who experienced natural menopause had a greater decrease in resting metabolic rate and physical activity during leisure time. Fasting insulin levels and the waist-to-hip ratio were also increased more in women who became postmenopausal. Menopause did not affect body weight, fasting glucose levels, energy intake, or peak VO2.
|
Discussion
|
|---|
|
|
|---|
Resting metabolic rate, the largest component of daily energy expenditure, regulates body weight, body composition, and daily energy needs [16]. Resting metabolic rate decreases with age in women, a process that is associated with the loss of fat-free mass [4]; however, the degree to which normal menopause accelerates this decrease is unclear. Cross-sectional data suggest that the decrease in resting metabolic rate and fat-free mass may be accelerated in postmenopausal women not receiving hormone replacement therapy [4, 17]. However, few previous longitudinal studies have been done on the effect of menopause on metabolic rate and body composition.
In our study, fat-free mass decreased by 3 kg and resting metabolic rate declined by approximately 100 kcal/d in postmenopausal women; no marked changes were noted in women who remained premenopausal. Thus, it is likely that resting energy requirements are lower in postmenopausal women because of the associated loss of metabolically active tissue.
We used a peak VO2 test to evaluate cardiovascular fitness and used an activity questionnaire to assess physical activity during leisure time. Postmenopausal women reported lower levels of leisure time physical activity than did premenopausal women, despite a similar decrease in peak VO2 in both groups. The decline in physical activity during leisure time may have been related to the increase in body fat and decline in fat-free mass seen in postmenopausal women. Although Wing and colleagues [11] did not measure body composition, they found greater weight gain in women who reported the largest decline in exercise-related behaviors over 3 years. Taken together, the decline in energy expenditure during rest and leisure (approximately 230 kcal/d), without a proportional reduction in energy intake, supports a period of positive energy imbalance that may be related to the increased fat mass seen in women who became postmenopausal.
Cross-sectional studies have reported discrepant results on the independent effects of menopause on body fat and fat distribution. Some investigators found an accelerated accumulation of fat in the intra-abdominal region [8, 9], whereas others found no independent menopause-related effect [17]. Our results support an increase in total body fat, which, as evidenced by the increase in the waist-to-hip ratio, is probably stored in central regions of the body. An increase in central body fat increases the risk for many chronic disorders, including atherosclerosis, hypertension, hypercholesterolemia, and insulin resistance [18]. Fasting insulin levels increased in women who experienced menopause, a finding consistent with those of previous longitudinal investigations [3]. This increased insulin level could be predicted because increased levels of total and intra-abdominal body fat are associated with higher levels of fasting insulin [17].
Our findings cannot establish cause and effect and cannot be extrapolated to other racial and ethnic groups. Larger sample sizes consisting of women receiving and not receiving hormone replacement therapy are needed to confirm and extend our preliminary observations regarding the energy imbalance of menopause and the possible therapeutic benefits of hormone replacement. Nevertheless, our longitudinal findings suggest that menopause is associated with an increase in the clustering of several metabolic and cardiovascular risk factors that were not found in age-matched women who remained premenopausal. Within this context, hormone replacement therapy prevents an increase in abdominal body fat in women immediately after menopause begins [19], and endurance exercise selectively reduces intra-abdominal body fat in older women [20]. Dietary, exercise, and hormonal interventions particularly targeted at premenopausal women may help mitigate the worsening cardiovascular and metabolic risk profile associated with menopause.
@copy; 1995 American College of Physicians
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Barrett-Connor E. Epidemiology and the menopause: a global over-view. Int J Fertil Menopausal Stud. 1993; 38(Suppl 1):6-14.
2. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. 1978; 89:157-61.
3. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989; 321:641-6.
4. Poehlman ET, Goran MI, Gardner AW, Ades PA, Arciero PJ, Katzman-Rooks SM, et al. Determinants of the decline in resting metabolic rate in aging females. Am J Physiol. 1993; 264(3 Pt 1):E450-5.
5. Arciero PJ, Goran MI, Poehlman ET. Resting metabolic rate is lower in women than in men. J Appl Physiol. 1993; 75:2514-20.
6. Gardner AW, Poehlman ET. Leisure time activity is a significant predictor of body density in men. J Clin Epidemiol. 1994; 47:283-91.
7. Aloia JF, McGowan DM, Vaswani AN, Ross P, Cohn SH. Relationship of menopause to skeletal and muscle mass. Am J Clin Nutr. 1991; 53:1378-83.
8. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992; 55:950-4.
9. Pasquali B, Casimirri F, Labate AM, Tortelli O, Pascal G, Anconetani B, et al. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Study. Int J Obesity Relat Metab Disord. 1994; 18:614-21.
10. Hjortland MC, Mcnamara PM, Kannel WB. Some atherogenic concomitants of menopause: The Framingham Study. Am J Epidemiol. 1976; 103:304-11.
11. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med. 1991; 151:97-102.
12. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol (Lond). 1949; 109:1-9.
13. Siri WE. Body composition from fluid spaces and density: analysis of methods. In: Brozek J, Henschel A, eds. Techniques for Measuring Body Composition. Washington, DC: National Research Council; 1961:223-44.
14. Taylor HL, Jacobs DR Jr, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978; 31:741-55.
15. "National Center for Health Statistics. Annual summary of births, marriages, divorces and deaths. United States, 1986. Monthly Vital Statistics Report. Volume 35, No. 13. DHHS No. (PHS) 87-1120. Hyattsville, MD: Public Health Services; August 24, 1987.".
16. Poehlman ET. Regulation of energy expenditure in aging humans. J Am Geriatr Soc. 1993; 41:552-9.
17. Wang Q, Hassager C, Ravn P, Wang S, Christiansen C. Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related? Am J Clin Nutr. 1994; 60:843-8.
18. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990; 10:497-511.
19. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991; 12:1323-6.
20. Schwartz RS, Shuman WP, Larson V, Cain KC, Fellingham GW, Beard JC, et al. The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism. 1991; 40:545-51.
Related articles in Annals:
This article has been cited by other articles:
![]() |
H. Volzke, S. Schwarz, S. E Baumeister, H. Wallaschofski, C. Schwahn, H. Jorgen Grabe, T. Kohlmann, U. John, and M. Doren Menopausal status and hepatic steatosis in a general female population Gut, April 1, 2007; 56(4): 594 - 595. [Full Text] [PDF] |
||||
![]() |
H. M. Kim, J. Park, S. Y. Ryu, and J. Kim The Effect of Menopause on the Metabolic Syndrome Among Korean Women: The Korean National Health and Nutrition Examination Survey, 2001 Diabetes Care, March 1, 2007; 30(3): 701 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. McInnes, A. Corbould, E. R. Simpson, and M. E. Jones Regulation of Adenosine 5',Monophosphate-Activated Protein Kinase and Lipogenesis by Androgens Contributes to Visceral Obesity in an Estrogen-Deficient State Endocrinology, December 1, 2006; 147(12): 5907 - 5913. [Abstract] [Full Text] [PDF] |
||||
![]() |
N TENTOLOURIS, S LIATIS, and N KATSILAMBROS Sympathetic System Activity in Obesity and Metabolic Syndrome Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 129 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Allison, P. Baldock, A. Sainsbury, R. Enriquez, N. J. Lee, E.-J. D. Lin, M. Klugman, M. During, J. A. Eisman, M. Li, et al. Conditional Deletion of Hypothalamic Y2 Receptors Reverts Gonadectomy-induced Bone Loss in Adult Mice J. Biol. Chem., August 18, 2006; 281(33): 23436 - 23444. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Sox and D. Rennie Research Misconduct, Retraction, and Cleansing the Medical Literature: Lessons from the Poehlman Case Ann Intern Med, April 18, 2006; 144(8): 609 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Sox Notice of Retraction: Final Resolution Ann Intern Med, May 3, 2005; 142(9): 798 - 798. [Full Text] [PDF] |
||||
![]() |
E. T. Poehlman Notice of Retraction: Final Resolution Ann Intern Med, May 3, 2005; 142(9): 798 - 798. [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Nicklas, B. W. J. H. Penninx, M. Cesari, S. B. Kritchevsky, A. B. Newman, A. M. Kanaya, M. Pahor, D. Jingzhong, and T. B. Harris Association of Visceral Adipose Tissue with Incident Myocardial Infarction in Older Men and Women: The Health, Aging and Body Composition Study Am. J. Epidemiol., October 15, 2004; 160(8): 741 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Kalantaridou, K. K. Naka, E. Papanikolaou, N. Kazakos, M. Kravariti, K. A. Calis, E. A. Paraskevaidis, D. A. Sideris, A. Tsatsoulis, G. P. Chrousos, et al. Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3907 - 3913. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, J. E Compston, N. E Day, M. Dowsett, and S. A Bingham The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial Am. J. Clinical Nutrition, February 1, 2004; 79(2): 326 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kantarci, I. Mihmanli, M. K. Demirel, K. Harmanci, C. Akman, F. Aydogan, A. Mihmanli, and O. Uysal Normal Diaphragmatic Motion and the Effects of Body Composition: Determination With M-Mode Sonography J. Ultrasound Med., February 1, 2004; 23(2): 255 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Sox Notice of Retraction Ann Intern Med, October 21, 2003; 139(8): 702 - 702. [Full Text] [PDF] |
||||
![]() |
M. D Sammel, J. A. Grisso, E. W Freeman, L. Hollander, L. Liu, S. Liu, D. B Nelson, and M. Battistini Weight gain among women in the late reproductive years Fam. Pract., August 1, 2003; 20(4): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Van Pelt, W. S. Gozansky, R. S. Schwartz, and W. M. Kohrt Intravenous estrogens increase insulin clearance and action in postmenopausal women Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E311 - E317. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Carr The Emergence of the Metabolic Syndrome with Menopause J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2404 - 2411. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kenny, L. Dawson, A. Kleppinger, M. Iannuzzi-Sucich, and J. O. Judge Prevalence of Sarcopenia and Predictors of Skeletal Muscle Mass in Nonobese Women Who Are Long-Term Users of Estrogen-Replacement Therapy J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2003; 58(5): M436 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shahar, S. Redline, T. Young, L. L. Boland, C. M. Baldwin, F. J. Nieto, G. T. O'Connor, D. M. Rapoport, and J. A. Robbins Hormone Replacement Therapy and Sleep-disordered Breathing Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ferrara, N. A. Lynch, B. J. Nicklas, A. S. Ryan, and D. M. Berman Differences in Adipose Tissue Metabolism between Postmenopausal and Perimenopausal Women J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4166 - 4170. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A Hughes, W. R Frontera, R. Roubenoff, W. J Evans, and M. A F. Singh Longitudinal changes in body composition in older men and women: role of body weight change and physical activity Am. J. Clinical Nutrition, August 1, 2002; 76(2): 473 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.C. Carr, A.F. Ayyobi, S.J. Murdoch, S.S. Deeb, and J.D. Brunzell Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 667 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D Hansen and B. J Allen Habitual physical activity, anabolic hormones, and potassium content of fat-free mass in postmenopausal women Am. J. Clinical Nutrition, February 1, 2002; 75(2): 314 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Ryan, B. J. Nicklas, and D. M. Berman Hormone Replacement Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women Diabetes Care, January 1, 2002; 25(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. O'Sullivan, A. Martin, and M. A. Brown Efficient Fat Storage in Premenopausal Women and in Early Pregnancy: A Role for Estrogen J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4951 - 4956. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Lovejoy, C. M Champagne, S. R Smith, L. de Jonge, and H. Xie Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: the Healthy Transitions Study Am. J. Clinical Nutrition, July 1, 2001; 74(1): 90 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferrara, A. J. Karter, L. M. Ackerson, J. Y. Liu, and J. V. Selby Hormone Replacement Therapy Is Associated With Better Glycemic Control in Women With Type 2 Diabetes: The Northern California Kaiser Permanente Diabetes Registry Diabetes Care, July 1, 2001; 24(7): 1144 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Evans, R. E. Van Pelt, E. F. Binder, D. B. Williams, A. A. Ehsani, and W. M. Kohrt Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women J Appl Physiol, June 1, 2001; 90(6): 2033 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Carr, J. E. Hokanson, A. Zambon, S. S. Deeb, P. H. R. Barrett, J. Q. Purnell, and J. D. Brunzell The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2831 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Santana, E. Zoico, E. Turcato, P. Tosoni, L. Bissoli, M. Olivieri, O. Bosello, and M. Zamboni Relation between body composition, fat distribution, and lung function in elderly men Am. J. Clinical Nutrition, April 1, 2001; 73(4): 827 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brochu, A. Tchernof, I. J. Dionne, C. K. Sites, G. H. Eltabbakh, E. A. H. Sims, and E. T. Poehlman What Are the Physical Characteristics Associated with a Normal Metabolic Profile Despite a High Level of Obesity in Postmenopausal Women? J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1020 - 1025. [Abstract] [Full Text] |
||||
![]() |
D. M. Berman, L. M. Rodrigues, B. J. Nicklas, A. S. Ryan, K. E. Dennis, and A. P. Goldberg Racial Disparities in Metabolism, Central Obesity, and Sex Hormone-Binding Globulin in Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 97 - 103. [Abstract] [Full Text] |
||||
![]() |
B. A. Gower and L. Nyman Associations among Oral Estrogen Use, Free Testosterone Concentration, and Lean Body Mass among Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4476 - 4480. [Abstract] [Full Text] |
||||
![]() |
R. Roubenoff and V. A. Hughes Sarcopenia: Current Concepts J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2000; 55(12): 716M - 724. [Abstract] [Full Text] |
||||
![]() |
M. Brochu, R. D. Starling, A. Tchernof, D. E. Matthews, E. Garcia-Rubi, and E. T. Poehlman Visceral Adipose Tissue Is an Independent Correlate of Glucose Disposal in Older Obese Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2378 - 2384. [Abstract] [Full Text] |
||||
![]() |
M. J. TOTH, A. TCHERNOF, C. K. SITES, and E. T. POEHLMAN Menopause-Related Changes in Body Fat Distribution Ann. N.Y. Acad. Sci., May 1, 2000; 904(1): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Gower, T. R. Nagy, M. I. Goran, A. Smith, and E. Kent Leptin in Postmenopausal Women: Influence of Hormone Therapy, Insulin, and Fat Distribution J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1770 - 1775. [Abstract] [Full Text] |
||||
![]() |
M. J. Toth, A. Tchernof, C. J. Rosen, D. E. Matthews, and E. T. Poehlman Regulation of Protein Metabolism in Middle-Aged, Premenopausal Women: Roles of Adiposity and Estradiol J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1382 - 1387. [Abstract] [Full Text] |
||||
![]() |
J. A. Kent-Braun, A. V. Ng, and K. Young Skeletal muscle contractile and noncontractile components in young and older women and men J Appl Physiol, February 1, 2000; 88(2): 662 - 668. [Abstract] [Full Text] |